When DL-isoleucine was added to an ammonium nitrate-maltose medium during cultivation of Streptomyces sp. 732, quinomycin B formation was selectively enhanced (from 3 to 70% of the quinomycin mixture) and quinomycin C synthesis was inhibited completely. In addition, two new quinomycins, designated quinomycins D and E, were produced in the presence of isoleucine. These compounds were found to contain N-methylalloisoleucine. In experiments with isoleucine enantiomorphs, it was determined that the order of effectiveness for quinomycin,B synthesis was DL-isoleucine > D-isoleucine > L-isoleucine. The extent to which quinomycin B synthesis is enhanced depends upon the concentration and the time of addition of isoleucine to the medium. The effect of DL-isoleucine was reduced to some extent by the addition of L-valine. It is conceivable that amino acids which are precursors of the N-methylamino acids in quinomycin can regulate quinomycin formation.
When DL-isoleucine was added to an ammonium nitrate-maltose medium during cultivation of Streptomyces sp. 732, quinomycin B formation was selectively enhanced (from 3 to 70% of the quinomycin mixture) and quinomycin C synthesis was inhibited completely. In addition, two new quinomycins, designated quinomycins D and E, were produced in the presence of isoleucine. These compounds were found to contain N-methylalloisoleucine. In experiments with isoleucine enantiomorphs, it was determined that the order of effectiveness for quinomycin,B synthesis was DL-isoleucine > D-isoleucine > L-isoleucine. The extent to which quinomycin B synthesis is enhanced depends upon the concentration and the time of addition of isoleucine to the medium. The effect of DL-isoleucine was reduced to some extent by the addition of L-valine. It is conceivable that amino acids which are precursors of the N-methylamino acids in quinomycin can regulate quinomycin formation.
Quinomycins A, B, and C are cyclic chromopeptide antibiotics which are synthesized by Streptomyces sp. 732 (14) . The chemical structure of quinomycin A (echinomycin) is shown in Fig. 1 . The sole difference between the quinomycins resides in the N-methylamino acid residues which are present in the peptide chains. Thus, quinomycin A contains 2 moles of N-methyl-L-valine (6), quinomycin B, 2 moles of N-methylalloisoleucine (7) , and quinomycin C, 2 moles of N,'y-dimethyl-L-alloisoleucine per mole of antibiotic (11) . Under the conditions generally employed for antibiotic synthesis by Streptomyces sp. 732, quinomycins A and C constitute the major components formed and quinomycin B is synthesized in trace amounts.
The presertt study was carried out to ascertain whether certain amino acids could influence the biosynthesis of the quinomycins. It was established that quinomycin B is the major component of the mixture formed in the presence of isoleucine. In addition, two new components, designated quinomycins D and E, were synthesized. Schmidt-Kastner (10) previously demonstrated that S. chrysomallus synthesizes actinomycins E1 and E2 in the presence of DL-isoleucine; actinomycins E1 and E2 possess one and two moles of N-methyl-isoleucine, respectively, in lieu of N-methyl-L-valine in the actinomycin peptide (1). It was reported that D-rather than L-isoleucine may preferentially stimulate the formation of these components (4) .
A preliminary report of the effect of isoleucine on quinomycin B synthesis by Streptomyces sp. 732 has been published (13) .
MATERIALS AND METHODS
Media. Inoculum medium contained: glucose, 20 g; peptone, 10 g; NaCl, 3 g; and CaCO3, 3 g; dissolved in 1,000 ml of tap water (pH 7.0, before sterilization). Amounts of 100 ml of medium were distributed in 300-ml Erlenmeyer flasks. Basal production medium (ammonium nitrate-maltose medium) contained: NH4NOs, 2 g; D-maltose, 20 g; K2HPO4, 1 g; MgS04.7H20, 0.25 g; ZnSO4.7H20, 0.1 g; CaCl,22H20, 0.05 g; and distilled water, 1,000 ml. The medium was prepared as follows. Ammonium nitrate and K2HP04 were dissolved in 500 ml of distilled water and the pH was adjusted to 6.9. D-Maltose and salts were dissolved in 500 ml of distilled water. Both solutions were separately autoclaved at 120 C for 20 min and were combined after being cooled. Peptone-agar consisted of 5 g of peptone and 20 g of agar, dissolved in 1,000 ml of tap water (pH 7.0, before sterilization).
Cultivation procedure. Streptomyces sp. 732 was maintained by monthly transfer on slants of Bennett's agar (12) . Slants were incubated for 7 days at 28 C and then were stored in the refrigerator. Amounts of 5 ml of 0.85% saline were added to slants, and a 1-ml sample of a spore suspension was inoculated into 100 ml of inoculum medium. After incubation for 48 hr at 28 C on a rotary shaking machine, the mycelium was harvested by centrifugation, washed twice with 0.85% saline, and finally suspended in approximately one-fifth the original volume. A 2-ml amount of the mycelial suspension was inoculated into 100 ml of 1327 basal production medium in a 300-ml Erlenmeyer flask and was incubated at 28 C on a rotary shaking machine (182 rev/min). A 4-mil amount of a suitable concentration of an amino acid solution was added to flasks at the time of inoculation unless noted otherwise.
Determination of quinomycin potency. At specified intervals, 2 ml of culture medium was transferred to a tube to which was added 2 ml of acetone. After intermittent shaking for 1 hr to complete extraction of quinomycins from cells, a filter-paper disc (10 mm Measurement of mycelium weight. Mycelium from 10-ml samples of medium was collected on a tared filter paper, washed with distilled water, and dried in an oven at 110 C for 3 hr. Growth was expressed as mycelium dry weight per milliliter of medium.
Chromatographic assay for quinomycin. Ascending paper chromatography was carried out on Toyo Roshi no. 50 filter paper (1 by 40 cm) with the lower phase of a solvent system which consisted of a 10% (w/v) aqueous solution of sodium o-cresotinate-n-butylether-sym-tetrachlorethane (3:2:1) (9). The paper strips were dipped in the aqueous phase of the solvent system, and excess moisture was removed by touching the strips with filter paper. A 10-,uliter amount of a concentrated solution of an acetone extract (containing approximately 4 to 8 ,ug of quinomycin) was applied to the origin of each strip, and the strips were then developed for approximately 15 hr. After drying in air, the paper strip was placed on the agar plate as described above and was removed after 20 min. Plates were then incubated overnight at 37 C. The biologically active quinomycin components synthesized in the presence and absence of isoleucine are shown in bioautograms in Fig. 2 Table 3 . DL-Isoleucine appears to be most effective for the enhanced synthesis of quinomycin B. Maximal synthesis of quinomycin B was observed even when DL-iSoleucine was supplied at a concentration of 0.6 mm. Synthesis of quinomycin C was completely abolished and only trace amounts of quinomycin A were produced. L-Isoleucine influenced quinomycin B formation, but only to a limited extent. As also shown in Table 3 , formation of quinomycin D and E was optimal when D-isoleucine was employed.
The influence of DL-isoleucine on quinomycin formation was examined in an experiment in which the racemate was supplied at different intervals during an incubation (Table 4) . It can be seen that the addition of DL-isoleucine at an early stage of synthesis is essential for maximal formation of quinomycin B. Influence of valine on the effect of DL-isoleucine. As the results indicate (Table 5 ), enhanced formation of quinomycin A (from 52 to 76%) was observed when L-valine was added to the medium; D-valine, at 10 mm, did not affect the (2) during studies of actinomycin biosynthesis. We observed that production of quinomycin B, normally synthesized in trace amounts, was markedly enhanced and quinomycin C formation was depressed when DL-isoleucine was added to the ammonium nitrate-maltose medium. The effect of isoleucine depends both on the concentration of the amino acid and on the time it is added to the medium. D-Isoleucine rather than its L-enantiomorph preferentially stimulates the formation of quinomycin B.
Structural studies, carried out by Otsuka and Shoji (8) , have revealed that quinomycin B compounds produced either in the absence or presence of DL-isoleucine possess different compositions of N-methylamino acids, although both show similar chromatographic behavior. Quinomycin B, normally synthesized in trace amounts, was later designated as quinomycin Bo, which contains N-methyl-L-valine and N,-y-dimethyl-L-alloisoleucine, whereas 2 moles of N-methylalloisoleucine are present in quinomycin B synthesized in the presence of DL-isoleucine (7). The mechanism for synthesis of this amino acid may proceed via L-isoleucine -> a-keto-,3-methylvaleric acid -k L-alloisoleucine --N-methylalloisoleucine. A similar mechanism was postulated by Katz et al. (4) for synthesis of N-methylisoleucine in actinomycins E1 and E2, which are synthesized by S. chrysomallus. Although certain similarities do exist in the effect of exogenous isoleucine upon quinomycin and actinomycin synthesis, several differences exist between the controlled biosynthetic processes. Quinomycin B synthesis is greater with DL-isoleucine than with the D isomer; L-isoleucine contributes to its formation to only a slight extent.
Although the reason for the superiority of DL-isoleucine to either isomer singly is not evident, one might suggest that L-isoleucine is more suitable as a precursor of N-methylalloisoleucine. Nevertheless, its rapid metabolism and the slow conversion of D isomer to L-alloisoleucine merits the retention of the concentration level of the precursor in the medium. Radioisotope studies should provide more definitive explanations of these mechanisms.
In contrast to the finding that D-isoleucine markedly inhibited actinomycin biosynthesis (3, 5) , there is virtually no change in overall production of the quinomycins when D-isoleucine is supplied (Table 3) ; moreover, in contrast to the results reported for actinomycin synthesis, D-valine does not inhibit quinomycin formation (Table 5 ).
In the presence of isoleucine, Streptomyces sp. 732 produces two new components (quinomycins D and E) in addition to quinomycin B. Structural studies reveal that one component (quinomycin D) contains N-methylalloisoleucine in addition to N-methyl-L-valine, whereas the other compound (quinomycin E) possesses N-methyl-alloisoleucine and N,'y-dimethyl-L-alloisoleucine (8) . As shown in Table 3 , quinomycin D was synthesized to a greater extent than quinomycin E, probably because quinomycin C synthesis, in contrast to quinomycin A formation, was markedly curtailed by DL-isoleucine.
Addition of L-valine and DL-isoleucine to the medium reduced somewhat the effect of isoleucine on quinomycin B synthesis and permitted greater synthesis of quinomycin A. It would appear, therefore, that exogenous isoleucine and valine compete with the amino acid produced endogenously for incorporation into the N-methyl amino acid site of the quinomycin peptide.
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